دورية أكاديمية
أعرض في EDS

Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus.

التفاصيل البيبلوغرافية
العنوان: Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus.
المؤلفون: Rees S; Bristol Trials Centre, University of Bristol, Bristol, UK., Arnold S; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK., Kherlopian A; Sydney Medical School, University of Sydney, Sydney, Australia., Fischer G; Sydney Medical School, University of Sydney, Sydney, Australia.
المصدر: Journal of lower genital tract disease [J Low Genit Tract Dis] 2024 Apr 01; Vol. 28 (2), pp. 183-188.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9704963 Publication Model: Print Cited Medium: Internet ISSN: 1526-0976 (Electronic) Linking ISSN: 10892591 NLM ISO Abbreviation: J Low Genit Tract Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: 2002- : Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: Malden, MA : Blackwell Science Inc., c1997-
مواضيع طبية MeSH: Lichen Sclerosus et Atrophicus*/drug therapy , Vulvar Lichen Sclerosus*/drug therapy , Dermatologic Agents*, Humans ; Female ; Glucocorticoids ; Adrenal Cortex Hormones/therapeutic use
مستخلص: Objectives: Some practitioners are adopting proactive topical corticosteroid (TCS) therapy for vulval lichen sclerosus (VLS). We sought to understand patient attitudes toward proactive TCS therapy for VLS in a context in which proactive therapy is adopted.
Methods: Four online focus group discussions with 12 participants. Data analysis was informed by social constructionist grounded theory.
Results: All participants had accepted a proactive regimen. Three themes were developed from the analysis: "Coming to accept proactive therapy," "Motivators to maintaining a proactive regimen," and "The importance of a routine that fits me." Within each theme are subthemes illustrating different dimensions of the theme.
Conclusions: Accepting proactive TCS therapy for VLS requires incorporating regular TCS use into a patient's identity, unlearning previous understandings regarding the safety of long-term TCS use, and adopting a regimen that fits within patients' lives and minimizes the loss of autonomy.
Competing Interests: The authors have declared they have no conflicts of interest.
(Copyright © 2024, ASCCP.)
References: Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol 2018;178:839–53.
Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 2017;31:e81–3.
Krapf JM, Mitchell L, Holton MA, et al. Vulvar lichen sclerosus: current perspectives. Int J Womens Health 2020;12:11–20.
Arnold S, Fernando S, Rees S. Living with vulval lichen sclerosus: a qualitative interview study. Br J Dermatol 2022;187:909–18.
Wehbe-Alamah H, Kornblau BL, Haderer J, et al. Silent no more! The lived experiences of women with lichen sclerosis. J Am Acad Nurse Pract 2012;24:499–505.
Bentham GL, Manley K, Halawa S, et al. Conversations between women with vulval lichen sclerosus: a thematic analysis of online forums. BMC Womens Health 2021;21:71.
Brauer M, van Lunsen R, Burger M, et al. Motives for vulvar surgery of women with lichen sclerosus. J Sex Med 2015;12:2462–73.
Yeon J, Oakley A, Olsson A, et al. Vulval lichen sclerosus: an Australasian management consensus. Australasian Journal of Dermatology 2021;62:292–9.
Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol 2015;151:1061–7.
Wijaya M, Lee G, Fischer G, et al. Quality of life in vulvar lichen sclerosus patients treated with long-term topical corticosteroids. J Low Genit Tract Dis 2021;25:158–65.
NIHR. Proactive against reactive therapy for the prevention of lichen sclerosus exacerbation and progression of disease a pragmatic, parallel group randomised controlled trial with embedded economic evaluation and process evaluation (PEARLS). 2022. Available at: https://www.fundingawards.nihr.ac.uk/award/NIHR135121 . Accessed November 30, 2023.
Alinia H, Moradi Tuchayi S, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. British Journal of Dermatology 2017;176:759–64.
Nic Dhonncha E, O'Connor C, O'Connell G, et al. Adherence to treatment with prescribed topical corticosteroid therapy and potential barriers to adherence among women with vulvar lichen sclerosus: a prospective cross-sectional study. Clin Exp Dermatol 2021;46:734–5.
O'Grady C, O'Connor C, Al Moosa A, et al. Burden of treatment in vulval lichen sclerosus. Skin Health and Disease 2022;2:e125.
Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr 1974;2:354–86.
Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985;20:29–37.
Rosenfeld D, Weinberg D. Domestic practice, situated contingency and adherence to medical directives: a call for research. Soc Theory Health 2012;10:42–60.
Carpenter CJ. A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Commun 2010;25:661–9.
Jones CJ, Smith H, Llewellyn C. Evaluating the effectiveness of health belief model interventions in improving adherence: a systematic review. Health Psychol Rev 2014;8:253–69.
Nicholls EJ, Rhodes T, Egede SJ. Situating adherence to medicines: the embodied practices and hinterlands of HIV antiretrovirals. Sociol Health Illn 2021;43:1085–99.
Charmaz K. Constructing Grounded Theory . Thousand Oaks: Sage; 2014.
Feldman SR, Vrijens B, Gieler U, et al. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol 2017;18:253–71.
Balasubramaniam P, Lewis F. Long-term follow-up of patients with lichen sclerosus: does it really happen? J Obstet Gynaecol 2007;27:282–2.
المشرفين على المادة: 0 (Glucocorticoids)
0 (Adrenal Cortex Hormones)
0 (Dermatologic Agents)
تواريخ الأحداث: Date Created: 20240322 Date Completed: 20240325 Latest Revision: 20240325
رمز التحديث: 20240325
DOI: 10.1097/LGT.0000000000000791
PMID: 38518216
قاعدة البيانات: MEDLINE
الوصف
تدمد:1526-0976
DOI:10.1097/LGT.0000000000000791